Investors tell Trinity Biotech to find a buyer
Company shares collapsed 50% after it withdrew key heart attack test
Trinity Biotech, the Bray-based maker of medical diagnosis equipment, has been told by investors to find a buyer for the company.
Trinity Biotech’s shares collapsed 50 per cent last week after it agreed to withdraw a key heart attack test from trial following concerns by regulators. Several investors in the company, whose shares trade on New York’s Nasdaq stock market, were also critical of its management team. The company said it would take a once-off...
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply